Calculation
Total asset turnover | = | Revenue1 | ÷ | Total assets1 | |
---|---|---|---|---|---|
Dec 31, 2020 | 0.43 | = | 3,239) | ÷ | 7,585) |
Dec 29, 2019 | 0.48 | = | 3,543) | ÷ | 7,316) |
Dec 30, 2018 | 0.48 | = | 3,333) | ÷ | 6,959) |
Dec 31, 2017 | 0.52 | = | 2,752) | ÷ | 5,257) |
Jan 1, 2017 | 0.56 | = | 2,398) | ÷ | 4,281) |
Jan 3, 2016 | 0.60 | = | 2,220) | ÷ | 3,688) |
Dec 28, 2014 | 0.56 | = | 1,861) | ÷ | 3,340) |
Dec 29, 2013 | 0.47 | = | 1,421) | ÷ | 3,019) |
Dec 30, 2012 | 0.45 | = | 1,149) | ÷ | 2,566) |
Jan 1, 2012 | 0.48 | = | 1,056) | ÷ | 2,196) |
Jan 2, 2011 | 0.49 | = | 903) | ÷ | 1,839) |
Jan 3, 2010 | 0.47 | = | 666) | ÷ | 1,430) |
Dec 28, 2008 | 0.42 | = | 573) | ÷ | 1,377) |
Dec 30, 2007 | 0.37 | = | 367) | ÷ | 988) |
Dec 31, 2006 | 0.61 | = | 185) | ÷ | 301) |
Jan 1, 2006 | 0.73 | = | 74) | ÷ | 101) |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
1 US$ in millions
Comparison to Competitors
Illumina Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2020 | 0.43 | 0.30 | 0.39 | 0.36 | 0.29 | 0.53 | 0.36 | 0.47 | 0.52 | 0.03 | 0.27 | 0.50 | 0.47 |
Dec 29, 2019 | 0.48 | 0.37 | 0.37 | 0.20 | 0.29 | 0.57 | 0.36 | 0.52 | 0.55 | 0.00 | 0.31 | 0.53 | 0.44 |
Dec 30, 2018 | 0.48 | 0.55 | 0.34 | 0.64 | 0.42 | 0.56 | 0.34 | 0.53 | 0.51 | 0.00 | 0.34 | 0.57 | 0.43 |
Dec 31, 2017 | 0.52 | 0.40 | 0.27 | 0.62 | 0.39 | 0.51 | 0.37 | 0.49 | 0.46 | — | 0.31 | 0.67 | 0.37 |
Jan 1, 2017 | 0.56 | 0.39 | 0.28 | 0.58 | 0.37 | 0.55 | 0.53 | 0.51 | 0.42 | — | 0.31 | 0.70 | 0.40 |
Jan 3, 2016 | 0.60 | 0.43 | 0.29 | 0.52 | 0.43 | 0.56 | 0.62 | 0.53 | 0.39 | — | 0.29 | 0.73 | 0.41 |
Dec 28, 2014 | 0.56 | 0.72 | 0.28 | 0.47 | 0.54 | 0.53 | 0.71 | 0.57 | 0.43 | — | 0.29 | 0.73 | 0.39 |
Dec 29, 2013 | 0.47 | 0.64 | 0.28 | 0.42 | 0.55 | 0.66 | 0.48 | 0.54 | 0.42 | — | 0.30 | 0.71 | 0.41 |
Dec 30, 2012 | 0.45 | 0.68 | 0.31 | 0.49 | 0.55 | 0.66 | 0.44 | 0.55 | 0.45 | — | 0.32 | 0.66 | 0.46 |
Jan 1, 2012 | 0.48 | — | 0.31 | 0.64 | 0.54 | 0.72 | 0.47 | 0.57 | 0.46 | — | 0.36 | 0.34 | 0.44 |
Jan 2, 2011 | 0.49 | — | 0.34 | 0.63 | 0.59 | 0.74 | 0.64 | 0.60 | 0.43 | — | 0.35 | 0.42 | 0.51 |
Jan 3, 2010 | 0.47 | — | 0.36 | 0.61 | 0.57 | 0.80 | 0.67 | 0.65 | 0.24 | — | 0.23 | 0.51 | 0.47 |
Dec 28, 2008 | 0.42 | — | 0.40 | 0.70 | 0.73 | 0.70 | 0.72 | 0.75 | 0.51 | — | 0.43 | 0.36 | 0.50 |
Dec 30, 2007 | 0.37 | — | 0.41 | 0.74 | 0.63 | 0.70 | 0.64 | 0.75 | 0.50 | — | 0.42 | 0.13 | 0.46 |
Dec 31, 2006 | 0.61 | — | 0.41 | 0.70 | 0.75 | 0.71 | 0.63 | 0.76 | 0.51 | — | 0.42 | 0.11 | 0.18 |
Jan 1, 2006 | 0.73 | — | 0.41 | 0.68 | 0.87 | 0.60 | 0.48 | 0.87 | 0.49 | — | 0.44 | 0.16 | 0.62 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Illumina Inc., total asset turnover, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
Illumina Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
---|---|---|
Dec 31, 2020 | 0.43 | 0.38 |
Dec 29, 2019 | 0.48 | 0.39 |
Dec 30, 2018 | 0.48 | 0.45 |
Dec 31, 2017 | 0.52 | 0.40 |
Jan 1, 2017 | 0.56 | 0.41 |
Jan 3, 2016 | 0.60 | 0.42 |
Dec 28, 2014 | 0.56 | 0.45 |
Dec 29, 2013 | 0.47 | 0.43 |
Dec 30, 2012 | 0.45 | 0.45 |
Jan 1, 2012 | 0.48 | 0.46 |
Jan 2, 2011 | 0.49 | 0.47 |
Jan 3, 2010 | 0.47 | 0.39 |
Dec 28, 2008 | 0.42 | 0.57 |
Dec 30, 2007 | 0.37 | 0.56 |
Dec 31, 2006 | 0.61 | 0.54 |
Jan 1, 2006 | 0.73 | 0.57 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
Comparison to Industry (Health Care)
Illumina Inc. | Health Care | |
---|---|---|
Dec 31, 2020 | 0.43 | 0.70 |
Dec 29, 2019 | 0.48 | 0.71 |
Dec 30, 2018 | 0.48 | 0.67 |
Dec 31, 2017 | 0.52 | 0.68 |
Jan 1, 2017 | 0.56 | 0.70 |
Jan 3, 2016 | 0.60 | 0.67 |
Dec 28, 2014 | 0.56 | 0.72 |
Dec 29, 2013 | 0.47 | 0.69 |
Dec 30, 2012 | 0.45 | 0.69 |
Jan 1, 2012 | 0.48 | 0.70 |
Jan 2, 2011 | 0.49 | 0.69 |
Jan 3, 2010 | 0.47 | 0.64 |
Dec 28, 2008 | 0.42 | 0.81 |
Dec 30, 2007 | 0.37 | 0.77 |
Dec 31, 2006 | 0.61 | 0.74 |
Jan 1, 2006 | 0.73 | 0.70 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).